Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Catalyst Biosciences Inc (CBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15037
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti-complement. Its pipeline products include factor VIIa marzeptacog alfa, for the treatment of individuals with hemophilia A and B; factor IX CB 2679d, for the treatment of hemophilia B; factor Xa variants, currently in research phase; and anti-C3: CB 2782, for treating dry age-related macular degeneration, ischemia-reperfusion injuries and inflammatory retinal diseases. The company partners with various international pharmaceutical companies to develop and commercialize its engineered human proteases. Catalyst Biosciences is headquartered in South San Francisco, California, the US.

Catalyst Biosciences Inc Key Recent Developments

Feb 08,2019: Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
Feb 06,2019: Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B
Dec 10,2018: Catalyst Biosciences to host a research & development day focused on factor VIIa and factor IX hemophilia programs
Dec 01,2018: Catalyst Biosciences Announces Updated Positive Interim Data from Its Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
Nov 01,2018: Catalyst Biosciences reports third quarter operating & financial results and provides a corporate update

This comprehensive SWOT profile of Catalyst Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Catalyst Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Catalyst Biosciences Inc – Key Information
Catalyst Biosciences Inc – Overview
Catalyst Biosciences Inc – Key Employees
Catalyst Biosciences Inc – Key Employee Biographies
Catalyst Biosciences Inc – Key Operational Heads
Catalyst Biosciences Inc – Major Products and Services
Catalyst Biosciences Inc – History
Catalyst Biosciences Inc – Company Statement
Catalyst Biosciences Inc – Locations And Subsidiaries
Catalyst Biosciences Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Catalyst Biosciences Inc – Business Description
Catalyst Biosciences Inc – Corporate Strategy
Catalyst Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Catalyst Biosciences Inc – Strengths
Catalyst Biosciences Inc – Weaknesses
Catalyst Biosciences Inc – Opportunities
Catalyst Biosciences Inc – Threats
Catalyst Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Catalyst Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Catalyst Biosciences Inc, Key Information
Catalyst Biosciences Inc, Key Ratios
Catalyst Biosciences Inc, Share Data
Catalyst Biosciences Inc, Major Products and Services
Catalyst Biosciences Inc, History
Catalyst Biosciences Inc, Key Employees
Catalyst Biosciences Inc, Key Employee Biographies
Catalyst Biosciences Inc, Key Operational Heads
Catalyst Biosciences Inc, Other Locations
Catalyst Biosciences Inc, Subsidiaries
Catalyst Biosciences Inc, Key Manufacturing facilities
Catalyst Biosciences Inc, Key Competitors
Catalyst Biosciences Inc, SWOT Analysis
Catalyst Biosciences Inc, Ratios based on current share price
Catalyst Biosciences Inc, Annual Ratios
Catalyst Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Catalyst Biosciences Inc, Performance Chart
Catalyst Biosciences Inc, Ratio Charts

★海外企業調査レポート[Catalyst Biosciences Inc (CBIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siem Offshore Inc (SIOFF):企業の財務・戦略的SWOT分析
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. It offers shipbuilding, ordering and delivery of new vessels, acquisition of modern second-hand …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • Nanosphere Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Virginia Electric and Power Company-エネルギー分野:企業M&A・提携分析
    Summary Virginia Electric and Power Company (Virginia Power), a subsidiary of Dominion Resources Inc., is a regulated energy utility that generates, transmits, and distributes electricity. It generates electricity from gas, nuclear, oil, coal, renewable, and biomass sources. The company also procure …
  • Tianjin Zhonghuan Semiconductor Co. Ltd. (002129):企業の財務・戦略的SWOT分析
    Tianjin Zhonghuan Semiconductor Co. Ltd. (002129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Biomatrica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Ikon Science Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Ikon Science Ltd (Ikon Science) is an oil and gas company that offers software technology and consulting services. The company provides RockDoc software. Its RokDoc software offers access to rock physics forward or reverse modeling, seismic inversion, log data synthesis, inversion feasibilit …
  • Idaho Power Co:企業の発電所・SWOT分析2018
    Idaho Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Ana Holdings Inc
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dana Brevini Spa:企業の戦略・SWOT・財務分析
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務分析
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zhongtian Technology Co., Ltd. (600522):企業の財務・戦略的SWOT分析
    Zhongtian Technology Co., Ltd. (600522) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Givaudan SA:企業の戦略・SWOT・財務情報
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Helijet International Inc.:企業の戦略・SWOT・財務分析
    Helijet International Inc. - Strategy, SWOT and Corporate Finance Report Summary Helijet International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Singapore Telecommunications Ltd:企業の戦略・SWOT・財務情報
    Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Telecommunications Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆